Ghent University Academic Bibliography

Advanced

Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype.

Chris Verhofstede UGent, Filip Van Wanzeele, Beatrijs Van Der Gucht, Nancy De Cabooter and Jean Plum (1999) AIDS. 13(18). p.2541-2546
abstract
Objectives: To study the effect of the interruption of reverse transriptase inhibitor (RTI) therapy or a switch from RTI to protease inhibitors, on the genotypic drug-resistance pattern of plasma HIV-1. Methods: Nine patients who completely stopped all medication, and five patients who switched from a treatment with RTI to a regimen containing protease inhibitors only, were studied. Direct sequencing of the plasma HIV-1 RT and protease gene was performed on follow-up samples taken before and after the interruption of treatment. Results: Comparison of the amino acid sequence of the RT and protease genes in successive samples showed the rapid reappearance of wild-type viral variants in 12 of the 14 patients studied. Wild-type virus replaced the mutant strains 14 days to 2 months after the interruption of therapy, even in patients with a long treatment history. Conclusion: The results of this study indicate the sustained lower fitness of mutant strains in vivo. As a result, wild-type virus remains capable of outcompeting the RT or protease mutant strains very fast after removal of the drug. These findings highlight the importance of 'treatment history' in addition to genotypic and phenotypic markers determined at one time-point, when making therapeutic decisions for patients.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
journal title
AIDS
Aids
volume
13
issue
18
pages
2541-2546 pages
Web of Science type
Article
Web of Science id
000084541200007
ISSN
0269-9370
language
English
UGent publication?
yes
classification
A1
id
170319
handle
http://hdl.handle.net/1854/LU-170319
date created
2004-01-14 13:40:00
date last changed
2016-12-19 15:45:20
@article{170319,
  abstract     = {Objectives: To study the effect of the interruption of reverse transriptase inhibitor (RTI) therapy or a switch from RTI to protease inhibitors, on the genotypic drug-resistance pattern of plasma HIV-1.

Methods: Nine patients who completely stopped all medication, and five patients who switched from a treatment with RTI to a regimen containing protease inhibitors only, were studied. Direct sequencing of the plasma HIV-1 RT and protease gene was performed on follow-up samples taken before and after the interruption of treatment.

Results: Comparison of the amino acid sequence of the RT and protease genes in successive samples showed the rapid reappearance of wild-type viral variants in 12 of the 14 patients studied. Wild-type virus replaced the mutant strains 14 days to 2 months after the interruption of therapy, even in patients with a long treatment history.

Conclusion: The results of this study indicate the sustained lower fitness of mutant strains in vivo. As a result, wild-type virus remains capable of outcompeting the RT or protease mutant strains very fast after removal of the drug. These findings highlight the importance of 'treatment history' in addition to genotypic and phenotypic markers determined at one time-point, when making therapeutic decisions for patients.},
  author       = {Verhofstede, Chris and Van Wanzeele, Filip and Van Der Gucht, Beatrijs and De Cabooter, Nancy and Plum, Jean},
  issn         = {0269-9370},
  journal      = {AIDS},
  language     = {eng},
  number       = {18},
  pages        = {2541--2546},
  title        = {Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype.},
  volume       = {13},
  year         = {1999},
}

Chicago
Verhofstede, Chris, FILIP VAN WANZEELE, BEATRIJS VAN DER GUCHT, NANCY DE CABOOTER, and Jean Plum. 1999. “Interruption of Reverse Transcriptase Inhibitors or a Switch from Reverse Transcriptase to Protease Inhibitors Resulted in a Fast Reappearance of Virus Strains with a Reverse Transcriptase Inhibitor-sensitive Genotype.” Aids 13 (18): 2541–2546.
APA
Verhofstede, C., VAN WANZEELE, F., VAN DER GUCHT, B., DE CABOOTER, N., & Plum, J. (1999). Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype. AIDS, 13(18), 2541–2546.
Vancouver
1.
Verhofstede C, VAN WANZEELE F, VAN DER GUCHT B, DE CABOOTER N, Plum J. Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype. AIDS. 1999;13(18):2541–6.
MLA
Verhofstede, Chris, FILIP VAN WANZEELE, BEATRIJS VAN DER GUCHT, et al. “Interruption of Reverse Transcriptase Inhibitors or a Switch from Reverse Transcriptase to Protease Inhibitors Resulted in a Fast Reappearance of Virus Strains with a Reverse Transcriptase Inhibitor-sensitive Genotype.” AIDS 13.18 (1999): 2541–2546. Print.